GENERAL
How India Could Reimagine Modern Water And Sanitation Programmes
In recent years, Indian government’s programmes and city-level reforms on water supply and sanitation have driven remarkable improvements, expanding networks, upgrading treatment capacity, and demonstrating that high-quality, customer-oriented services are achievable. Several cities now provide continuous water supply, have dramatically reduced losses, or have achieved impressive levels of wastewater reuse and solid-waste processing, according to […]
CW Bureau
·
Mar 23, 2026
GENERAL
Power Sector Charges Ahead: 520 GW Milestone Triggers Next Phase
India’s power sector is entering a high-growth, high-transformation phase, with installed capacity surpassing 520 GW, one of the fastest expansions globally. Backed by rising demand, policy momentum, and rapid renewable adoption, the sector is positioning itself as a cornerstone of India’s economic and industrial growth. Electricity demand is projected to surge by over 30% by […]
CW Bureau
·
Mar 22, 2026
GENERAL
West Asia Crisis: Commercial LPG Curbs Eased To Support Industries
After bringing in normalcy in delivery of domestic LPG cylinders, the government has now stepped up efforts to improve the supply of commercial LPG which had been curtailed earlier. This move is aimed at supporting businesses reduce operational costs, and enhance energy security across sectors such as hospitality, manufacturing and small enterprises. In view of […]
CW Bureau
·
Mar 22, 2026
GENERAL
Critical Mineral Blocks To Go Under Hammer In New Auction Tranche
The Indian government is set to launch the seventh tranche of auctions for critical and strategic mineral blocks on March 23, 2026. The latest tranche will offer 19 mineral blocks spread across multiple states under mining leases and composite licences. These blocks include a diverse range of minerals vital for sectors such as clean energy, […]
CW Bureau
·
Mar 22, 2026
GENERAL
Generic Semaglutide Arrives, Igniting Race For India’s Diabetes Market
The expiry of the Semaglutide patent in India has triggered a high-stakes entry of domestic pharma majors into the GLP-1 therapy space, setting the stage for intense price competition and wider patient access. With type 2 diabetes and obesity emerging as major public health challenges, companies are racing to capture a share of what is […]
Sajan C Kumar
·
Mar 21, 2026
GENERAL
NCLT Clears Next Step In Veranda Learning’s Commerce Demerger
The National Company Law Tribunal (NCLT), Chennai Bench, has moved the proposed demerger of Veranda Learning Solutions’ commerce vertical a step forward, directing the company to convene a meeting of its equity shareholders on April 24, 2026, via video conferencing. The meeting will consider and approve the Composite Scheme of Arrangement involving Veranda Learning Solutions […]
CW Bureau
·
Mar 21, 2026
GENERAL
Pharma Growth Surge Positions India At The Heart Of Global Healthcare
The domestic pharmaceutical market, currently valued at $ 60 billion, is projected to more than double to $130 billion by 2030. In FY25, the sector recorded an annual turnover of ₹4.72 lakh crore, with exports growing at a steady CAGR of 7% over the past decade. India’s dominance in generic medicines, accounting for nearly 20% […]
CW Bureau
·
Mar 21, 2026
GENERAL
AFMD Honours Research Excellence, Top Scientists Awarded In Chennai
The 2nd International Conference on Advanced Functional Materials and Devices (AFMD 2026), hosted by the SRM Institute of Science and Technology’s Nanotechnology Research Centre, emerged as a significant global platform for scientific exchange, recognising excellence in advanced materials research. Held at the Dr. T.P. Ganesan Auditorium, the conference attracted over 1,000 participants, including 160 international […]
CW Bureau
·
Mar 21, 2026
GENERAL
India Opens Global Bidding For Rare Earth Magnet Manufacturing Plants
The ministry of heavy industries has invited global bids for setting up integrated sintered rare earth permanent magnet (REPM) manufacturing facilities in India, marking a major step towards strengthening the country’s advanced manufacturing ecosystem. The request for proposal (RFP), released on March 20, 2026, seeks to identify beneficiaries to establish a total capacity of 6,000 […]
CW Bureau
·
Mar 21, 2026
GENERAL
Dr Reddy’s Launches Semaglutide Generic Injection For Diabetes Care
Dr Reddy’s Laboratories has announced the launch of Obeda, its injectable Semaglutide, marking a significant milestone in expanding access to advanced GLP-1 receptor agonist therapies for the treatment of type 2 diabetes in India. The company claimed that it is the first Indian player to secure approval from the Drugs Controller General of India (DCGI) […]
CW Bureau
·
Mar 21, 2026
